Kelyniam Global Company Description

Kelyniam Global, Inc., a medical device manufacturing company, engages in the production of custom prosthetics cranial implants utilizing computer aided design, and computer aided manufacturing of advanced medical grade polymers in the United States.

The company is also involved in the development, manufacture, and distribution of custom cranial and maxilla-facial implant for patients requiring the reconstruction of cranial and facial structures.

It serves surgeons, health systems, and payors. The company was formerly known as Ketner Global Investments, Inc. and changed its name to Kelyniam Global, Inc. in December 2007.

Kelyniam Global, Inc. was incorporated in 2005 and is based in Collinsville, Connecticut.

Kelyniam Global, Inc.

Country	United States
Founded	2005
Industry	Medical Devices
Sector	Healthcare
Employees	20
CEO	Ross Bjella

Contact Details

Address: 97 River Road Collinsville, Nevada 06019 United States
Phone	800 280 8192
Website	kelyniam.com

Stock Details

Ticker Symbol	KLYG
Exchange	OTCMKTS
Fiscal Year	January - December
Reporting Currency	USD
ISIN Number	US4883591004
SIC Code	3841

Key Executives

Name	Position
Ross Bjella	Chairman and Chief Executive Officer
Terrance Kurtenbach	Chief Financial Officer
Michael Hamblett	Director of Investor Relations
James Barrow Esq.	General Counsel and Director of Quality and Regulatory
Dr. Mark V. Smith M.D.	Vice President of Sales and Business Development and Director
Dr. Christopher Mirucki	Chief Medical Officer